New UK headquarters for Bristol-Myers Squibb
pharmafile | December 5, 2005 | News story | Sales and Marketing | BMS, UK
Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.
The £5.5 million building houses over 200 employees, and BMS says the offices symbolise its commitment to working and investing in the UK.
In a special message, delivered for the occasion, Jane Kennedy minister of state for health, said: “The pharmaceutical industry creates huge benefits in both treating patients, and bringing investment into the UK. Bristol-Myers Squibb’s £5.5 million investment in Uxbridge demonstrates its continued commitment to the UK.”
She also reconfirmed the government’s determination to maintain the UK as a good business environment for the industry and indicated that BMS research into cancer, diabetes and obesity was in line with the government’s own priorities in health.
BMS is the sixth largest supplier of hospital products to NHS hospitals, and has launched three major new products in the UK over the last two years in the areas of schizophrenia, HIV and analgesia.
David Veitch, European vice-president and general manager of Bristol-Myers Squibb UK, said: “Bristol-Myers Squibb is a pharmaceutical company that is looking confidently to the future; the modern, open and innovative design of our new head office reflects this confidence.”
The company’s late-stage pipeline includes a promising new first-in-class treatment for rheumatoid arthritis, Orenica (abatacept).
The drug is set to gain final FDA approval in early 2006. But the future of another late-stage drug, muraglitizar, looks gloomy, with BMS and partner Merck now considering abandoning its development following FDA requests for significantly more safety data.
Related Content
Addenbrooke’s hospital offers first self-service digital eye test
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing …
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online …
Deadly cancers are being financially left behind, new research claims
New research has revealed that some of the UK’s most deadly and prevalent cancers receive …
